One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Active glomerular inflammation versus chronicity and fibrosis: the role of targeted therapies in IgA nephropathy
doi : 10.1093/ndt/gfaf059
Volume 40, Issue 10, October 2025
Rituximab-induced persistent hypogammaglobulinemia in children with nephrotic syndrome: common or rare?
doi : 10.1093/ndt/gfaf103
Novel and traditional B-cell depleting agents for IgG4-related disease: a critical view
doi : 10.1093/ndt/gfaf108
The evolving spectrum of kidney amyloidosis: advances in diagnosis, typing and treatment
doi : 10.1093/ndt/gfaf042
Acute post-streptococcal glomerulonephritis in children—treatment standard
doi : 10.1093/ndt/gfaf130
Dietary vitamin E and tocopherol isoform intake and the progression of chronic kidney disease
doi : 10.1093/ndt/gfaf052
Comparison of estimated glomerular filtration rate equations on prediction of mortality, kidney failure and acute kidney injury
doi : 10.1093/ndt/gfaf054
Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands
doi : 10.1093/ndt/gfaf060
Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD
doi : 10.1093/ndt/gfaf064
A meta-analysis of graft survival, patient survival and delayed graft function in first-time and repeat kidney transplants
doi : 10.1093/ndt/gfaf066
Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry
doi : 10.1093/ndt/gfaf067
Plasma trimethylamine N-oxide concentration and all-cause mortality in kidney transplant recipients
doi : 10.1093/ndt/gfaf071
Temporal trends in the treatment of relapsing minimal change podocytopathy—a binational cohort study
doi : 10.1093/ndt/gfaf072
Acute kidney injury in very old patients—incidence, severity, risk factors and short-term outcomes
doi : 10.1093/ndt/gfaf074
Matrix metalloproteinase (MMP)-10 aggravates podocyte injury in glomerulonephritis
doi : 10.1093/ndt/gfaf076
How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA
doi : 10.1093/ndt/gfaf069
Hyperkalemia risk of finerenone versus spironolactone in CKD patients with type 2 diabetes
doi : 10.1093/ndt/gfaf098
Correction to: Kidney thrombotic microangiopathy with concurrent monoclonal gammopathy
doi : 10.1093/ndt/gfaf140
